Personalized Medicine and the Impact on the Pharmaceutical Company

Sanjiv S. Agarwala, MD

Video Categories: Personalized Medicine

Dr Agarwala hypothesizes how the future of the traditional pharmaceutical company may change with the developments in personalized medicine.
January 4, 2017

Serotonin and Carcinoid Tumors

Hal Gerstein, MD,¬†details this neurotransmitter’s role in the development of carcinoid tumors and carcinoid syndrome.¬†

March 24, 2015

In Pursuit of Targeted Therapies

As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.